16, Dec 2025
Everyday Environmental Toxins Raise Growing Concerns for Breast Health
Hyderabad, Dec 16:- Breast health begins with awareness. It’s more than routine check-ups, it’s about understanding the hidden risks woven into our everyday lives. From the plastics we use to the air we breathe, certain chemicals and pollutants can quietly affect our hormones and long-term breast health, often without us even realizing it.
Take common chemicals like BPA and phthalates. These are often found in plastic bottles, food packaging, cosmetics, and even fragrances. They’re known as endocrine disruptors, meaning they can mimic or interfere with natural hormones such as estrogen. Lab studies show that these chemicals can change how breast cells grow, raising questions about a possible link to cancer.
However, research in humans hasn’t given us a clear answer yet. Some studies, even one from India found higher levels of phthalates in women with breast cancer, while many larger global studies have not seen the same pattern. Experts agree that more long-term research is needed, but most recommend reducing unnecessary exposure as a sensible precaution.
Thankfully, small everyday choices can help;
• Don’t heat food in plastic containers
• Use glass or stainless steel whenever possible
• Choose fragrance-free or “clean” personal care products
• Support eco-friendly practices that reduce plastic and chemical pollution
Air pollution is another growing concern for breast health. Long-term exposure to pollutants like NO₂ and PM2.5 may slightly increase breast cancer risk. These pollutants can cause inflammation and damage to breast cells over time. A recent U.S. National Institutes of Health study even found higher rates of certain hormone-related breast cancers in women exposed to high levels of PM2.5. Still, scientists caution that more evidence is needed, since these studies observe trends rather than proving cause and effect.
While science continues to explore the link between environmental toxins and breast health, one thing remains clear: prevention goes beyond medicine. Cleaner air, safer products, and mindful daily habits not only strengthen breast health, they help build a healthier, more sustainable world for everyone.
- 0
- By Neel Achary
15, Dec 2025
FUJIFILM India Expands Advanced MRI Access in East with APERTO Lucent Installation in Siliguri
Siliguri, Dec 15: FUJIFILM India, a leader in advanced diagnostic imaging solutions, has announced the installation of its state-of-the-art APERTO Lucent Open MRI system at Mothercare Centre Airport Plaza Building Bagdogra Naxalbari Block Close to Siliguri District, Darjeeling, strengthening a partnership that spans more than a decade. The centre, led by Director, Dr. Ranjit Bhagat, has long relied on FUJIFILM India’s CR, DR and ultrasound technologies, and this latest installation marks a transformative step forward in expanding high-quality MRI access for communities across North Bengal.

The APERTO Lucent brings together precision imaging and patient-centric design, offering a uniquely open, comfortable scanning experience through its single-pillar structure and True OPEN Bore architecture. Equipped with a 0.4T permanent magnet, the system delivers stable, high-clarity imaging at low running costs, while its IP-RAPID technology significantly reduces scan times without compromising detail, helping clinicians diagnose complex neurological, musculoskeletal, cardiac, and oncological conditions with greater accuracy and efficiency.
The city, Siliguri, functions as a critical healthcare hub for a vast regional population spanning North Bengal, Sikkim, Bihar and the North-East, where access to advanced imaging has historically been uneven and sometimes delayed. With India steadily expanding MRI availability beyond large cities, the installation of this machine in Siliguri aims to bridge these gaps by offering faster, more accurate diagnosis within the region and ensuring that high-quality care is accessible to every family without the burden of long-distance travel.
Dr. Ranjit Bhagat, Director, Mother Care Center, added, “At Mother Care Center, our priority has always been to give patients access to the best possible care, supported by reliable and advanced technology. The APERTO Lucent Open MRI is a significant step forward for us, it delivers superior image quality while offering a more comfortable experience, especially for patients who feel anxious in closed scanners. This upgrade strengthens our ability to diagnose with confidence and ensures that our community benefits from modern, high-precision imaging right here in Siliguri.”
Speaking on the milestone, Mr. Shunsuke Honda, Business Advisor, Medical Systems Division, FUJIFILM India, said, “At FUJIFILM India, improving access to advanced imaging is central to our mission. Many communities in North Bengal and neighbouring regions have long faced delays in reaching specialised diagnostic services, and installations like this help bring high-quality MRI closer to the people who need it most. Our partnership with Mother Care Center reflects our commitment to strengthening regional healthcare infrastructure and ensuring that world-class imaging is not limited to metro cities. With the APERTO Lucent Open MRI, we aim to support more equitable, timely and patient-friendly diagnostics across Siliguri and nearby cities.”
This installation reinforces FUJIFILM India’s commitment to strengthening diagnostic ecosystems in emerging healthcare hubs, ensuring that access to advanced, equitable, and patient-friendly imaging continues to expand across the country.
12, Dec 2025
Aster Prime Hospital conducts three day Health Camp at Meridian School for the Students
Hyderabad, Dec 12:- Doctors emphasized that students the future citizens of the nation must prioritize their health, as staying healthy is essential for focusing on academics. A free medical camp was organized at Meridian School, Banjara Hills, under the supervision of doctors from Aster Prime Hospital. With the support of the Meridian Group of Schools Management, Principal, and Vice Principal of the Banjara Hills branch, the camp was smoothly conducted over three days, Wednesday, Thursday and Friday.
A total of 410 students from Grade 5 to Grade 12 underwent various health screenings. The tests included height, weight, BMI, body temperature, pulse rate, and eye check-ups. Students were first examined by General Medicine doctors, followed by Pediatric specialists. Dermatologists also performed thorough evaluations to check for any skin-related issues.
Doctors educated the students on the importance of a balanced and nutritious diet, advising them to avoid junk food and consume clean, home-cooked meals. They also stressed proper hand hygiene before eating.
The medical camp featured expert participation from Aster Prime Hospital’s Consultant Pediatricians Dr. Rishivardhan Reddy and Dr. T. Narendra, Consultant Dermatologist Dr. Harini, and Consultant Gynecologist Dr. Tanuja Paipuru.
11, Dec 2025
Leptospirosis Risk Surges as Extended Monsoon Hits Mumbai Region
Mumbai, Dec 11: A coordinated medical response at Wockhardt Hospitals, Mira Road helped save the life of Mrs. Seema Dhumal (name changed), 51, from Khar who arrived in a near-exsanguinated state due to severe leptospirosis. Her sudden decline and multi-organ failure placed her among the most critical cases seen this year. Her recovery now highlights the importance of early awareness and timely treatment during the monsoon season.
Mrs. Dhumal reached Wockhardt Hospitals, Mira Road with acute respiratory distress, heavy bleeding, and severe lung involvement. She showed blood loss from the mouth, lungs, and endotracheal tube. The team found she had DIC, a dangerous clotting disorder, and acute kidney failure that required urgent dialysis. Patients with this mix of issues face high risk and need fast, structured action.

Under the leadership of Dr. Aklesh Tandekar, Head and Consultant of Critical Care, experts from Critical Care, Nephrology, Pulmonology, Infectious diseases, and Hematology team worked in full coordination at Wockhardt Hospitals, Mira Road. The team used advanced ventilation strategies, dialysis support, blood products, and strict round-the-clock monitoring.
As care progressed, her bleeding stopped. Her lungs cleared. Her clotting system stabilised. Her kidneys responded to dialysis support. In time, she was weaned off the ventilator, marking a major turning point in her recovery.
Dr. Tandekar noted that this case shows the strength of fast diagnosis, tight teamwork, and evidence-based intensive care.
Today, Mrs. Dhumal is stable and improving at Wockhardt Hospitals, Mira Road. The hospital urges the public to stay alert for early symptoms of leptospirosis, avoid stagnant water, wear protective footwear, and seek medical help without delay.
Areas with high population density like Mumbai, Thane, Navi Mumbai, and the Vasai–Virar region face high risk of leptospirosis during the monsoon. This year, the monsoon extended two extra months, which raised exposure to contaminated water. By October 2024, these zones reported 18 deaths.Data from the Economic Survey of Maharashtra 2024–25 shows a sharp rise in leptospirosis deaths statewide. Maharashtra recorded 26 deaths in 2024, up from eight in 2023. That is a 225% increase, even though cases dropped from 1,484 in 2023 to 953 in 2024.
Leptospirosis spreads when people come in contact with water mixed with urine from infected animals, mainly rats. Rat urine carries the bacteria and can enter the body through small cuts in the skin. Flooded roads, waterlogging, and poor waste control raise this risk.
11, Dec 2025
MediGlo Clinic Launches “Exion,” a Needle-Free Skin Treatment in Gurugram
Dec 11:- MediGlo Clinic, a leader in advanced skincare innovation, has announced the launch of Exion, an advanced needle-free treatment designed to safely and effectively address a wide range of skin concerns.

Exion provides a completely non-invasive option for individuals seeking youthful, radiant skin without the pain, discomfort, or downtime associated with traditional dermatological procedures. The treatment is particularly effective for concerns such as fine lines, uneven skin texture, pigmentation, dullness, and loss of elasticity.
Powered by cutting-edge technology, Exion gently stimulates natural collagen production, boosts skin hydration, and enhances overall skin luminosity, making it suitable for all skin types. With zero needles involved, the experience is comfortable even for clients who prefer to avoid injectables or invasive therapies while still achieving visible, long-lasting results.
Speaking about the launch, the MediGlo Clinic team shared,
“Exion reflects our ongoing commitment to delivering innovative, patient-centric skincare. We are thrilled to introduce a treatment in Gurugram that offers both efficacy and comfort, giving clients an advanced yet gentle pathway to glowing, rejuvenated skin.”
Exion is now available at MediGlo Clinic, Gurugram, offering residents a modern, needle free approach to skin rejuvenation. The launch further strengthens the clinic’s mission to provide accessible, effective, and comfort-driven skincare solutions that align with global advancements in aesthetic care.
With Exion, MediGlo continues to redefine skincare by blending innovation, safety, and sophistication—empowering clients to achieve healthy, youthful skin effortlessly.
11, Dec 2025
Mauritius President Inaugurates Dr Agarwal’s New Corneal & Pinhole Eye Facility
President of Mauritius Inaugurates Dr Agarwals Eye Hospitals Corneal Transplant & Pinhole Pupilloplasty Facility, Marking the Group’s Expansion into Mauritius
Chennai, Dec 11: Dr Agarwals Eye Hospital, one of India’s prominent eye-care groups, has expanded its international presence with the launch of a Specialised Corneal Transplant & Pinhole Pupilloplasty Centre at Ebene, Mauritius. Inaugurated by His Excellency Mr Dharambeer Gokhool G.C.S.K., President of the Republic of Mauritius, the facility marks an important step in strengthening India–Mauritius healthcare collaboration and improving access to advanced corneal care in the region.

With the launch of this centre, a range of advanced corneal procedures developed and refined in India, including PDEK (Pre-Descemet’s Endothelial Keratoplasty), CAIRS (Corneal Allogenic Intrastromal Ring Segment) and Pinhole Pupilloplasty will now be accessible to patients in Mauritius and neighbouring African nations. These specialised techniques, pioneered by surgeons at Dr Agarwals Eye Hospital, reflect India’s growing contribution to global ophthalmic innovation.
Speaking at the inauguration, His Excellency Mr Dharambeer Gokhool G.C.S.K., President of the Republic of Mauritius, said,
“The launch of this specialised eye care centre reflects the growing collaboration between Mauritius and India in the healthcare sector. It will enhance access to advanced ophthalmic care for patients in Mauritius and the wider region.”
Speaking on the occasion, Prof. Amar Agarwal, Chairman, Dr Agarwals Group of Eye Hospitals, said,
“This launch reinforces our long-standing vision to take India’s ophthalmic innovations to the world. Our presence in Mauritius is not just an expansion it is a commitment to collaborate, share knowledge, and make modern eye care accessible globally. We are deeply honoured that His Excellency, the President of Mauritius, inaugurated this facility, showing strong belief in innovation-led healthcare.”
Dr. Ashar Agarwal, Chief Business Officer, added,
“Mauritius offers a strong ecosystem for advancing healthcare delivery. Through this specialised centre, we aim to build clinical capacity, enable skill transfer, and strengthen regional access to advanced ophthalmic care. This initiative aligns with our broader mission of addressing avoidable blindness globally.”
The Mauritius centre further strengthens Dr Agarwals Eye Hospital’s international presence. The group operates over 250 centres across India, Africa, and Southeast Asia, serving more than 2 million patients annually. Over the years, the hospital has developed and introduced widely recognised techniques such as Glued IOL, PDEK, SFTP, and CAIRS, reflecting India’s growing contribution to ophthalmic innovation.
10, Dec 2025
Centre for Sight Moradabad Introduces Advanced Retina Surgery with Dr. Upasna Singh
Moradabad, Dec 10: Centre for Sight, India’s leading chain of super-specialty eye hospitals, proudly announces the launch of its Advanced Surgical Retina Services in Moradabad, a significant step forward in expanding access to world-class retinal care across Western Uttar Pradesh. The milestone is marked by the joining of Dr. Upasna Singh, an accomplished vitreoretinal surgeon, as Senior Consultant Vitreoretinal Services.
Founded in 1996 by Padma Shri Awardee Prof. (Dr.) Mahipal S. Sachdev, Centre for Sight has grown into one of India’s most trusted eye care networks, with 90+ centres across 30+ cities, a team of 350+ expert doctors, and nearly three decades of clinical excellence. Each year, the network provides advanced and ethical eye care to over 15 lakh patients, covering specialties such as cataract, refractive surgeries, cornea, glaucoma, retina, pediatric ophthalmology, oculoplasty, and ocular oncology.
The newly inaugurated Surgical Retina Unit at Centre for Sight Moradabad is equipped to diagnose and manage complex retinal disorders including diabetic retinopathy, retinal detachment, age-related macular degeneration (ARMD), macular holes, epiretinal membranes, and advanced vitreoretinal diseases. With next-generation diagnostics and cutting-edge surgical technologies, patients in Moradabad and nearby regions will no longer need to travel to larger cities for specialised retinal treatment.
Centre for Sight Moradabad is delighted to welcome Dr. Upasna Singh, who brings with her a rich blend of academic excellence, surgical expertise, and a deeply patient-centered approach. Dr. Singh completed her MBBS from Government Medical College, Miraj (MUHS) and went on to pursue MS Ophthalmology at MLN Medical College, Prayagraj (KGMU). She further refined her expertise with a Fellowship in Vitreoretinal Surgery at Sadguru Netra Chikitsalaya, Chitrakoot, one of India’s most respected institutes for retinal care. Before joining Centre for Sight, she served as Assistant Professor at Autonomous State Medical College (ASMC), Pratapgarh), contributing significantly to both clinical practice and surgical training.
Speaking on the launch, Dr. Upasna Singh said
“Retinal diseases often progress silently and demand early intervention to prevent irreversible vision loss. With the introduction of Surgical Retina Services in Moradabad, patients can now access advanced diagnostics and specialised retinal surgeries closer to home. I am honoured to join Centre for Sight and look forward to serving the community with compassion, precision, and the latest surgical innovations.”
Prof. (Dr.) Mahipal S. Sachdev, Chairman & Medical Director, Centre for Sight, said
“At Centre for Sight, our focus has always been on ensuring high-quality, ethical, and accessible care for every patient. The launch of Surgical Retina Services in Moradabad, led by Dr. Upasna Singh, reflects our commitment to bringing world-class expertise and technology to underserved regions. This expansion strengthens our mission of transforming lives through better vision.”
Dr. Lalit Mohan, Medical Director, Centre for Sight Moradabad, further added
“The introduction of Surgical Retina Services marks a major advancement for eye care in Moradabad. With Dr. Upasna Singh’s expertise and our upgraded infrastructure, patients suffering from complex retinal diseases can now receive timely, specialised care right here in the city. This initiative reinforces our promise of delivering compassionate, comprehensive, and technologically advanced treatment to every patient.”
With this development, Centre for Sight reaffirms its commitment to delivering advanced, ethical, and high-quality eye care across India.
10, Dec 2025
Spinz Expands Glow Skincare Portfolio, Enters High-Growth De-Tan Segment
Chennai, Dec 10: Spinz, the flagship skincare brand from the house of FMCG major CavinKare, today announced a significant expansion of its glow-focused skincare portfolio with the launch of the Spinz DeTan Face Pack. Building on the strong consumer response to its BB Cream and India’s first-ever BB Face Powder, the brand is now entering the high-growth detan skincare segment with a product designed to deliver complete glow care from daily enhancement to weekly rejuvenation. Spinz’s entry into the detan category marks a strategic step in offering consumers a more holistic, end-to-end glow regimen. The new DeTan Face Pack debuts on leading e-commerce platforms, reflecting the brand’s intent to strengthen its presence in the digital-first skincare space.

The Spinz DeTan Face Pack features an advanced no-bleach formulation, crafted to gently clear tan and impurities while deeply nourishing the skin. With rising sun exposure and increased time spent outdoors, tanning has become a common skin concern – often leaving the complexion looking dull, uneven, and fatigued.
Enriched with honey, Besan & Kojic, Spinz’s DeTan Face Pack works to exfoliate the dead skin cells, reduce dullness, to reveal brighter, more even-toned skin with 100% salon like glow at home, within just 15 minutes of application. While honey helps soothe and moisturize the skin, besan gently lifts impurities and excess oil, and Kojic works to lighten pigmentation, together creating a powerful blend for visible brightness and clarity. This potent trio not only targets dullness at the root but also boosts the skin’s natural radiance. Dermatologically tested, the product is suitable for all skin types and ideal for regular weekly use.
Commenting on the launch, Mr. Rajat Nanda, Business Head – Personal Care, CavinKare, said,
“Glow has always been at the heart of Spinz’s skincare proposition. With the launch of the Spinz DeTan Face Pack, we are expanding this promise by giving consumers a complete glow solution, from everyday radiance with Spinz BB Cream and BB Face Powder to deeper rejuvenation with this detan face pack. The segment presents immense potential, driven by rising skincare awareness, self-care trends and a strong preference for salon-like results at home. This launch not only strengthens our skincare portfolio but also reinforces Spinz’s commitment to making high-performance glow care accessible to all.”
9, Dec 2025
Scrub Typhus on the Rise: Key Prevention Tips for 2025
Hyderabad, Dec 9:- Andhra Pradesh is witnessing an unusual spike in Scrub typhus cases this season, with more than 174 confirmed infections and Visakhapatnam reporting over 130 cases, according to state health officials. The disease, which has already claimed eight lives, is prompting renewed attention to preventive health and personal immunity.
Scrub typhus is not new to India, but its rising incidence in rural and semi-urban pockets has become a growing concern. The infection is caused by a bacterium called Orientia tsutsugamushi, spread through the bite of infected chiggers tiny larval mites found in grassy, bushy, and wooded areas. The CDC notes that the illness is common in parts of Southeast Asia, the Indian subcontinent, and other tropical regions.
How the Disease Spreads;
People generally contract scrub typhus when they come into contact with vegetation where infected mites are present. Farmers, field workers, children playing outdoors, and individuals living near dense greenery are at higher risk. Symptoms often begin with fever, body aches, headache, and may escalate if untreated.
Prevention Is the Strongest Defence;
Public health experts emphasise simple but effective prevention measures:
- Avoid sitting or sleeping directly on grass.
- Wear full-sleeved clothing when in fields or forested areas.
- Keep surroundings clean and free from overgrown vegetation.
- Seek immediate medical attention if fever develops after outdoor exposure.
Can Immunity Play a Role?
While environmental precautions are essential, many doctors believe that strong baseline immunity can influence how the body responds to infections.
Hyderabad-based classical homeopathy practitioner Dr. Anubbha explains that long-term constitutional care can help improve an individual’s resistance to seasonal and vector-borne illnesses.
“In classical homeopathy, each remedy is tailored to the person’s genetic constitution. When immunity is strengthened, the body becomes less reactive to infectious triggers. We observed this even during COVID-19—patients with consistent constitutional support tended to cope better,” she says.
According to Dr. Anubbha, classical homeopathy does not act as a vaccine, but it enhances the body’s internal defence system, helping individuals remain more resilient when exposed to infections like scrub typhus.
Holistic Prevention Matters;
Experts agree that a combined approach works best:
- Environmental care to reduce exposure
- Timely diagnosis to prevent complications
- Immunity-building practices, including classical homeopathy, for long-term resilience
As scrub typhus cases continue to rise in Andhra Pradesh, a stronger focus on prevention and personal immunity can help communities stay prepared and protected.
Dr. Anubbha, BHMS,
Classical Homeopathy Specialist,
Dr. Anubbha’s Homeopathy, Kondapur & Masab Tank.
8, Dec 2025
Indo–Italian Medical Consensus Sounds Alarm on Paediatric Sarcoma; Experts Urge Action on Early Diagnosis
Bengaluru, Dec 8: Indo–Italian experts from India, Italy, Malaysia, and Singapore convened in Bengaluru for the Indo–Italian Consensus Meet on Sarcoma and Complex Orthopaedic Reconstruction, held on December 5th & 6th at Bengaluru. The two-day conference, is a collaborative medical conference organised by the Global Healthcare Academy, focusing on paediatric/adult sarcoma care, complex reconstructions, 3D printing, regenerative medicine, and precision orthopaedic oncology via expert panels and hands-on workshops.

Experts at the meet advised that late detection, misdiagnosis, and gaps in national cancer policy continue to cost young lives and limbs. The conference, themed “Sarcoma Advances, Genomics & Immunotherapy,” brought together more than 200 leading specialists in orthopedics, oncology, paediatric oncology, radiology, and reconstructive surgery for high-level discussions, live demonstrations, and consensus building on clinical protocols.
The deliberations were led by eminent global faculty, including Dr. B.S. Ajaikumar, Founder & Chairman, HealthCare Global Enterprises Ltd; Dr. Pramod Chinder, Orthopaedic Surgeon and Group Director – Orthopaedic Oncology, HCG Cancer Centre; Dr. Marco Manfrini, Orthopaedic Surgeon, Istituto Ortopedico Rizzoli, Bologna; Dr. Laura Campanacci, Musculoskeletal Oncology, Istituto Ortopedico Rizzoli, Bologna; as well as keynote speakers Dr. Vivek Ajit Singh, Professor and Head of Orthopaedic Oncology, University Malaya, and Dr. Kumaran Rasappan, Adjunct Assistant Professor, National University of Singapore.
Dr. B. S. AjaiKumar, Founder & Chairman, HealthCare Global Enterprises Ltd said that
“Sarcomas are preventable when diagnosed early and treated the right way, the first time. The Indo-Italian Consensus Meet marks an important milestone in bringing together global expertise to complement and strengthen our standards of care. By increasing awareness, ensuring rapid access to MRI, and establishing a national Sarcoma Registry, we can enable timely diagnosis, higher limb-salvage rates, and equitable care for patients across India – whether they live in Bengaluru or in a small rural town. The central goal in sarcoma management is to prevent recurrence. This is only possible when every patient – child or adult – receives evidence-based, multidisciplinary, first-time-right treatment. Over several decades, HCG has built one of the largest sarcoma programs in the country. Our experience – particularly that of Dr. Pramod Chinder, who has treated more than 5,000 sarcoma cases – shows that these cancers can be definitively treated with strong long-term outcomes when handled correctly from the outset.
While international protocols provide a basic scientific platform, our true strength lies in making these guidelines patient-centric and India-specific. We refine them using our own extensive clinical data, high case volumes, and deep understanding of disease patterns unique to Indian patients. With the integration of genomics, precision diagnostics, and innovative treatment planning, we continue to improve outcomes and ensure that no patient is denied the chance of a cure.”
He further added that
“One of the most compelling examples of what timely, expert, multidisciplinary care can achieve is the limb-saving surgery Dr. Pramod performed on a 20-day-old newborn – an outcome that reflects the level of expertise now available in our country and underscores what is possible with the right approach. With continued collaboration, scientific rigor, and a national commitment to early detection, we can significantly reduce recurrence rates and ensure that every sarcoma patient – child, adolescent, or adult – receives world-class, first-time-right care.
Imagine a young person waking night after night with leg pain, dismissed as growing pain or a sports injury – until scans finally reveal bone cancer. This is the reality we must change. It reinforces why early diagnosis and timely, first-time-right treatment are absolutely critical.”
Experts highlighted that sarcomas are often diagnosed late in India, particularly in children, because early signs are frequently overlooked by parents and primary care physicians. Symptoms such as swelling around the knees or shoulders or persistent pain are commonly mistaken for minor injuries, leading to avoidable delays. Population-based cancer registry data reinforce this concern, showing that 68% of Ewing Sarcoma cases occur in the 0–19 age group, with the highest incidence in children aged 10–14 years.
Parents are advised to watch for red flags such as persistent bone pain for weeks, night pain, a growing lump or swelling, limping or reduced mobility, fractures from minor injuries, and unexplained fever, weight loss, or fatigue. These symptoms warrant immediate medical evaluation.
Dr. Pramod S. Chinder, Orthopaedic Surgeon, Group Director – Orthopaedic Oncology, HCG Cancer Hospital, said:
“The biggest tragedy in sarcoma care is when a child loses a limb simply because the first surgery was not done right. Early MRI, correct biopsy, and a multidisciplinary approach are non-negotiable. Our collaboration with leaders from the Rizzoli Orthopaedic Institute, Italy, brings world-class limb-salvage techniques, 3D-printed implants, and precision navigation to Indian practice.”
He further added that this partnership will directly strengthen clinical pathways, reduce misdiagnosis, and help save more limbs and more childhoods across India. Over 15 years, “We have managed more than 6,000 bone tumours, including up to 3,000 sarcomas, and our experience shows one clear truth that sarcomas are highly curable when treated correctly the first time. With proper chemotherapy, high-quality limb-salvage surgery, and standardised reconstruction, long-term survival exceeds 70%, and our survivors go on to become doctors, engineers, entrepreneurs, and athletes.”
In India, cancers affecting the bones and muscles make up only about 1% of all cancers, making them among the rarest forms; yet they are nearly 70% curable when diagnosed early and treated appropriately, especially in children. The Indo–Italian collaboration holds particular significance as India’s policy framework for bone and muscle sarcomas is still evolving, while Italy’s sarcoma program is widely regarded as a global gold standard.
According to Dr. B. S. AjaiKumar, this conference marks a Significant step toward developing an organized Sarcoma Registry for India, a crucial requirement in today’s AI-driven healthcare era, where accurate data and precision-guided care can significantly improve survival outcomes.
Specialists cautioned that sarcoma outcomes worsen when the first surgery is performed incorrectly, often due to swelling being mistaken for infection or a harmless lesion. Such errors can lead to improper incisions or incomplete tumour removal, severely limiting limb-salvage options.
The meet highlighted advanced technologies transforming sarcoma care, including robotic navigation, 3D-printed implants, targeted chemotherapy, and image-guided minimally invasive treatments. Experts noted that these innovations, supported by genomics and immunotherapy, are dramatically improving limb-salvage success.
Despite being highly treatable when diagnosed early, sarcomas remain excluded from most public health schemes, leaving families with significant financial burdens. Experts called for insurance coverage, wider MRI access, regional referral centres, and a mandatory national Sarcoma Registry to improve timely, equitable care.
